EMA’s CHMP recommended the approval yesterday Approval based on results from four phase III studies in over 5,500 patients Actemra/RoActemra has also been provisionally approved in Australia for the treatment of COVID-19 Basel, 07 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for... Read more
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studies The European Commission is expected to make a final decision regarding approval in the near future Basel, 06 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency’s... Read more
Bones provide the scaffold for all movements of vertebrate animals. Bone has been studied extensively, typically with the hope to understand how to better heal and grow this tissue; however, little is understood about its evolutionary origin. While our bones have osteocytes, which are cells embedded in our bones, not all species’ bones do. This... Read more
Chicago, November 28, 2021: GE Healthcare is proud to unveil SIGNA Hero[i], a new 3.0T magnetic resonance imaging (MRI) system named in honor of all the global healthcare workers who continue caring for our global community amidst today’s COVID-19 pandemic. Offering new workflows and AIR Recon DL enhancements, SIGNA Hero is designed to help those... Read more
24 November 2021 Oxford Instruments was saddened to learn of the death of our founder, Sir Martin Wood, 94, on 23 November after a short illness. We offer our sincere condolences to his wife Audrey, and their extended family, during this difficult time. Oxford Instruments was started in Martin and Audrey’s garden shed in 1959.... Read more
Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for millions of patients worldwide. Access to accurate and reliable diagnostic tests help clinicians improve patient care, limit healthcare spending and contribute to protecting public health. The cobas 5800 System is... Read more
Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend Strong Double-Digit Growth Quarter Underscores Robust Demand Environment in Life Sciences CHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of... Read more
New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ — As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD)... Read more
Consolidated Financial Statements for the Second Quarter Ended September 30, 2021 FY2022 (April 1, 2021 – March 31, 2022) [UNAUDITED] | IR News | News Release ＆ IR News | Investor Relations Read more